v3 Template
A

Aplagon

Biopharmaceutical ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$13.2M
Funding Rounds
2
Last Funding
2026-06-16

About Aplagon

Aplagon is a clinical stage biopharmaceutical company focused on developing first-in-class therapeutics for thromboinflammatory diseases, including thrombotic and vascular occlusion-related cardiovascular diseases, which contribute to a significant number of global deaths.

Products & Services

APAC Therapeutic:A unique vascular injury targeting molecule with triple action as an antiplatelet, anticoagulant, and anti-inflammatory agent, designed to combat a wide range of thromboinflammatory diseases.

Specialties

Thromboinflammatory diseases Cardiovascular diseases Therapeutics development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity
T: -
FT: Equity 		A: 5600000
MR: -
FA: 4.8 million
FAN: 5600000 		D: 2026-06-16
FD: 2026-06-16 		5 investors
2 RT: Financing Round
T: -
FT: Financing Round 		A: 7560000
MR: -
FA: EUR 7 Million
FAN: 7560000 		D: 2025-02-03
FD: 2025-02-03 		5 investors
Equity Latest
2026-06-16
$5.6M
5 investors (Pro only)
Financing Round 2025-02-03
$7.6M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Steven Myint

Non-Executive Director, MD, PhD, Professor

A

Alexander Cohen

MD, PhD, Professor

D

Douglas Cines

MD, PhD, Professor

A

Anders Albäck

MD, PhD, Associate Professor

G

Gijs van Dedem

CMC

J

Jonathan Himmelfarb

MD, PhD, Professor

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Aplagon Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~380 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro